Court Rules for Plaintiff in $10.5 Million Accutane Lawsuit: AttorneyOne.com Warns the Threat from Accutane's Severe Adverse Events Remains

According to court documents, on February 27th, 2012 the New Jersey Supreme Court ruled that Kamie S. Kendall, the plaintiff in a $10.5 million lawsuit over Accutane, did not miss the state's two-year statute of limitations when she filed the suit in 2005 (A-73-2010 – 066802). Accutane (isotretinoin), a popular acne medication introduced in 1982, is manufactured by Hoffman-LaRoche, Inc. Kendall, who accuses Accutane for her ulcerative colitis, started taking Accutane for her acne in 1997, when she was twelve years old and she was awarded over $10.5 million by a jury in a 2008 trial. In 2009, as the number of lawsuits against the company kept increasing, Accutane was pulled from the US market. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Accutane's severe adverse events http://www.attorneyone.com/accutane-lawsuit/.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Accutane severe adverse effects threat

Accutane severe adverse effects threat

ulcerative colitis is associated with previous isotretinoin (the active ingredient in Accutane) exposure

San Diego, CA (PRWEB) March 14, 2012

The media spotlight is often a double-edged sword. No one knows this better than Kamie S. Kendall. And yet, gossip and rumor-mongering aside, the real story here is being overlooked, according to Sean Burke of AttorneyOne.

On February 27th, 2012, the New Jersey Supreme Court ruled that Kamie S. Kendall, the plaintiff in a $10.5 million Accutane Lawsuit, did not miss the state's two-year statute of limitations when she filed the suit in 2005 (A-73-2010 – 066802). Accutane (isotretinoin), a popular acne medication introduced in the early 1980s, is manufactured by Hoffman-LaRoche, Inc. Kendall, who accuses Accutane for her ulcerative colitis, started taking Accutane for her acne in 1997, when she was twelve years old. Two years later, she began having stomach problems, though she continued taking Accutane after being hospitalized. According to the lawsuit, Accutane allegedly caused inflammatory bowel disease (IBD), including ulcerative colitis, which is characterized by frequent and often bloody bowel movements, pain and other symptoms. In a 2008 trial Kendall was awarded over $10.5 million by a jury.

Results of the study conducted by researchers from the University of North Carolina, Chapel Hill, and published on the American Journal of Gastroenterology in September 2010, showed that ulcerative colitis is associated with previous isotretinoin (the active ingredient in Accutane) exposure.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of Accutane severe adverse events, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that the threat of severe side effects from Accutane remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

About 13 million people have taken Accutane since it went on the market in 1982. In June 2009, Hoffman-LaRoche announced a recall of the medication.

AttorneyOne.com has further information on Accutane Lawsuit including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. Checkout earlier legal news from us at http://www.prweb.com/releases/2012/3/prweb9266216.htm.